BR112016016737A2 - Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma - Google Patents
Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasmaInfo
- Publication number
- BR112016016737A2 BR112016016737A2 BR112016016737A BR112016016737A BR112016016737A2 BR 112016016737 A2 BR112016016737 A2 BR 112016016737A2 BR 112016016737 A BR112016016737 A BR 112016016737A BR 112016016737 A BR112016016737 A BR 112016016737A BR 112016016737 A2 BR112016016737 A2 BR 112016016737A2
- Authority
- BR
- Brazil
- Prior art keywords
- anaplasma
- methods
- peptides
- devices
- detection
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 241000606646 Anaplasma Species 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 238000001514 detection method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 208000006730 anaplasmosis Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Abstract
PEPTÍDEOS, DISPOSITIVOS E MÉTODOS PARA DETECÇÃO DE ANTICORPOS CONTRA ANAPLASMA. A invenção fornece populações de peptídeos isolados, úteis para a detecção de anticorpos que se ligam a antígenos de Anaplasma. As populações de peptídeos compreendem os peptídeos derivados de fragmentos imunogênicos das proteínas de Proteína de Membrana Externa de Anaplasma. A invenção também proporciona dispositivos, métodos e kits compreendendo as populações de peptídeos isolados, úteis para a detecção de anticorpos que se ligam a antígenos de Anaplasma e o diagnóstico da anaplasmose. Os métodos de identificação da espécie particular de Anaplasma infectando um sujeito utilizando as populações de peptídeos da invenção são também divulgados.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461929655P | 2014-01-21 | 2014-01-21 | |
US61/929,655 | 2014-01-21 | ||
US14/511,916 US9194870B2 (en) | 2014-01-21 | 2014-10-10 | Peptides, devices, and methods for the detection of Anaplasma antibodies |
US14/511,916 | 2014-10-10 | ||
PCT/US2015/012187 WO2015112558A2 (en) | 2014-01-21 | 2015-01-21 | Peptides, devices, and methods for the detection of anaplasma antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016016737A2 true BR112016016737A2 (pt) | 2017-10-03 |
BR112016016737B1 BR112016016737B1 (pt) | 2024-01-02 |
Family
ID=53544557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016016737-6A BR112016016737B1 (pt) | 2014-01-21 | 2015-01-21 | Composição, método para detectar numa amostra um anticorpo para um epítopo de um antígeno de anaplasma, método para o diagnóstico da anaplasmose num sujeito, kit, e método para identificar as espécies de anaplasma infectando um sujeito |
Country Status (12)
Country | Link |
---|---|
US (4) | US9194870B2 (pt) |
EP (2) | EP3096784B1 (pt) |
JP (1) | JP6738274B2 (pt) |
KR (1) | KR102559678B1 (pt) |
CN (1) | CN105916518A (pt) |
AU (1) | AU2015209461B2 (pt) |
BR (1) | BR112016016737B1 (pt) |
CA (1) | CA2933376C (pt) |
ES (1) | ES2767183T3 (pt) |
HU (1) | HUE047156T2 (pt) |
PT (1) | PT3096784T (pt) |
WO (1) | WO2015112558A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9133525B2 (en) | 2012-01-26 | 2015-09-15 | Luc Montagnier | Detection of DNA sequences as risk factors for HIV infection |
US9194870B2 (en) | 2014-01-21 | 2015-11-24 | Abaxis, Inc. | Peptides, devices, and methods for the detection of Anaplasma antibodies |
US9956123B2 (en) * | 2016-03-02 | 2018-05-01 | Alphal Engineering Technology Group, Inc. | Anti-microbial balanced weave wearable undergarment and process therefore |
EP3428646A4 (en) * | 2016-03-09 | 2019-10-23 | Dai Nippon Toryo Co., Ltd. | COMPOSITION FOR IDENTIFYING A SUBSTANCE TO BE INVESTIGATED WITH GOLD PANELS AND USE THEREOF |
CN106324253A (zh) * | 2016-08-12 | 2017-01-11 | 江苏泽成生物技术有限公司 | 一种***抗体测定试剂盒及其检测方法 |
BR102017002668A2 (pt) | 2017-02-09 | 2018-10-30 | Biotick Pesquisa E Desenvolvimento Tecnologico Ltda | peptídeo híbrido, conjunto de peptídeos híbridos, composição, usos do peptídeo híbrido, método de induzir resposta imune e kits |
CN107137060B (zh) * | 2017-04-14 | 2019-11-05 | 同济大学 | 一种易代谢的金纳米球/鸡卵清蛋白复合纳米光声探针及其制备 |
JP7041491B2 (ja) * | 2017-10-31 | 2022-03-24 | 田中貴金属工業株式会社 | バイオアッセイのための検出剤及びそれを用いたシグナルの増幅方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4366246A (en) | 1977-11-08 | 1982-12-28 | Genentech, Inc. | Method for microbial polypeptide expression |
US5965702A (en) | 1991-10-21 | 1999-10-12 | Abbott Laboratories | Borrelia burgdorferi antigens and uses thereof |
US5618533A (en) | 1992-02-11 | 1997-04-08 | Yale University | Flagellin-based polypeptides for the diagnosis of lyme disease |
US5932220A (en) | 1995-05-08 | 1999-08-03 | Board Of Regents University Of Texas System | Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
US6716574B2 (en) | 1996-05-02 | 2004-04-06 | Dako A/S | Osp-C derived peptide fragments |
US6207169B1 (en) | 1997-03-21 | 2001-03-27 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
US6403093B1 (en) | 1997-03-21 | 2002-06-11 | Mayo Foundation For Medical Education And Research | Methods to detect granulocytic ehrlichiosis |
US6231869B1 (en) | 1997-03-21 | 2001-05-15 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
US6204252B1 (en) | 1997-04-25 | 2001-03-20 | Aquila Biopharmaceuticals, Inc. | Characterization of granulocytic ehrlichia and methods of use |
CA2258266A1 (en) | 1997-04-25 | 1998-11-05 | Aquila Biopharmaceuticals, Inc. | Nucleic acids, proteins, and methods of use of granulocytic ehrlichia |
WO1999013720A1 (en) | 1997-09-19 | 1999-03-25 | The Ohio State Research Foundation | Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis |
US6436399B1 (en) | 1998-04-09 | 2002-08-20 | The Ohio State University Research Foundation | Nucleic acid encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
US6355777B1 (en) | 2000-04-28 | 2002-03-12 | Research Development Foundation | P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
US20030194756A1 (en) | 2002-04-12 | 2003-10-16 | O'connor Thomas Patrick | Peptides for detection of antibody to Ehrlichia equi |
US7407770B2 (en) | 2001-01-18 | 2008-08-05 | Idexx Corporation | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
US7204992B2 (en) | 2002-11-04 | 2007-04-17 | Clayton Foundation For Research | P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
US7304139B2 (en) | 2003-10-28 | 2007-12-04 | University Of Florida Research Foundation, Inc. | Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
US20060046310A1 (en) | 2004-08-25 | 2006-03-02 | Zong-Li Xia | Amplification method for solid phase immunoassays |
US7390626B2 (en) | 2005-02-25 | 2008-06-24 | Immunosciences Lab., Inc. | Methods and kit for diagnosing tick borne illnesses |
EP1891095A2 (en) | 2005-06-16 | 2008-02-27 | Research Development Foundation | Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
PL1895015T3 (pl) | 2005-06-17 | 2013-02-28 | Inst De Salud Carlos Iii | Sposób i zestaw do wykrywania gatunków bakteryjnych za pomocą analizy DNA |
WO2007133623A2 (en) | 2006-05-10 | 2007-11-22 | Biopeptides Corporation | Peptide diagnostic agent for lyme disease |
US7776618B2 (en) | 2007-03-01 | 2010-08-17 | Church & Dwight Co., Inc. | Diagnostic detection device |
US7507789B2 (en) | 2007-04-09 | 2009-03-24 | Idexx Laboratories, Inc. | Detection of Anaplasma platys |
US8784828B2 (en) | 2007-05-04 | 2014-07-22 | The Ohio State University Research Foundation | Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
ES2327593B1 (es) | 2007-06-29 | 2010-08-05 | Instituto De Salud Carlos Iii | Metodo de identificacion de especies bacterianas de los generos anaplasma/ehrlichia y bartonella. |
US8158370B2 (en) | 2007-11-27 | 2012-04-17 | Idexx Laboratories, Inc. | Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma |
TWI586365B (zh) | 2008-10-08 | 2017-06-11 | 英代斯實驗公司 | 用於偵測對嗜吞噬細胞邊蟲(aph)及片狀邊蟲(apl)具專一性之抗體之組合物及方法 |
US8257938B2 (en) | 2009-02-27 | 2012-09-04 | Medical Diagnostic Laboratories, Llc | Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum |
WO2011063003A2 (en) | 2009-11-17 | 2011-05-26 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
JP6161291B2 (ja) * | 2009-11-20 | 2017-07-12 | アバクシス, インコーポレイテッド | エールリッヒア抗体の検出のためのペプチド、装置、および方法 |
US8455211B2 (en) | 2010-07-15 | 2013-06-04 | Medical Diagnostic Laboratories, Llc | Anaplasma translocated substrate-1 (ATS-1) and sero-detection of Anaplasma phagocytophilum |
US20140162256A1 (en) | 2011-03-31 | 2014-06-12 | Yasuko Rikihisa | Compositions and methods for the detection of anaplasma platys |
US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
CN105051541B (zh) | 2012-10-11 | 2017-07-04 | 爱贝斯股份有限公司 | 用于检测埃里希体属抗体的肽、装置和方法 |
US9194870B2 (en) | 2014-01-21 | 2015-11-24 | Abaxis, Inc. | Peptides, devices, and methods for the detection of Anaplasma antibodies |
-
2014
- 2014-10-10 US US14/511,916 patent/US9194870B2/en active Active
-
2015
- 2015-01-21 AU AU2015209461A patent/AU2015209461B2/en active Active
- 2015-01-21 BR BR112016016737-6A patent/BR112016016737B1/pt active IP Right Grant
- 2015-01-21 WO PCT/US2015/012187 patent/WO2015112558A2/en active Application Filing
- 2015-01-21 EP EP15740392.4A patent/EP3096784B1/en active Active
- 2015-01-21 HU HUE15740392A patent/HUE047156T2/hu unknown
- 2015-01-21 EP EP19209648.5A patent/EP3636277A1/en active Pending
- 2015-01-21 KR KR1020167022271A patent/KR102559678B1/ko active IP Right Grant
- 2015-01-21 CA CA2933376A patent/CA2933376C/en active Active
- 2015-01-21 JP JP2016547569A patent/JP6738274B2/ja active Active
- 2015-01-21 ES ES15740392T patent/ES2767183T3/es active Active
- 2015-01-21 PT PT157403924T patent/PT3096784T/pt unknown
- 2015-01-21 CN CN201580005151.9A patent/CN105916518A/zh active Pending
- 2015-10-16 US US14/885,443 patent/US9702883B2/en active Active
-
2017
- 2017-06-21 US US15/628,864 patent/US10330687B2/en active Active
-
2019
- 2019-05-09 US US16/407,565 patent/US11131675B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2015112558A3 (en) | 2015-09-03 |
US9194870B2 (en) | 2015-11-24 |
EP3636277A1 (en) | 2020-04-15 |
JP6738274B2 (ja) | 2020-08-12 |
JP2017505436A (ja) | 2017-02-16 |
AU2015209461B2 (en) | 2019-08-22 |
US20190277857A1 (en) | 2019-09-12 |
BR112016016737B1 (pt) | 2024-01-02 |
ES2767183T3 (es) | 2020-06-16 |
WO2015112558A2 (en) | 2015-07-30 |
KR102559678B1 (ko) | 2023-07-27 |
US20160109457A1 (en) | 2016-04-21 |
PT3096784T (pt) | 2020-01-21 |
CN105916518A (zh) | 2016-08-31 |
US9702883B2 (en) | 2017-07-11 |
US20170363639A1 (en) | 2017-12-21 |
AU2015209461A1 (en) | 2016-06-30 |
US10330687B2 (en) | 2019-06-25 |
CA2933376A1 (en) | 2015-07-30 |
EP3096784B1 (en) | 2019-11-20 |
EP3096784A2 (en) | 2016-11-30 |
EP3096784A4 (en) | 2017-12-06 |
HUE047156T2 (hu) | 2020-04-28 |
CA2933376C (en) | 2023-09-26 |
US11131675B2 (en) | 2021-09-28 |
KR20160108521A (ko) | 2016-09-19 |
US20150204868A1 (en) | 2015-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016016737A2 (pt) | Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma | |
CL2020000192A1 (es) | Anticuerpos anti-cd8 y usos de estos. | |
BR112018070260A2 (pt) | receptores quiméricos e métodos de uso dos mesmos | |
CO2018011668A2 (es) | Neoantígenos y métodos de su uso | |
BR112017017293A2 (pt) | método para predizer modificações de aminoácidos, para selecionar e/ou classificar modificações de aminoácidos e para fornecer uma vacina e vacina | |
BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
EA201791148A1 (ru) | Способ определения абсолютных количеств hla-рестриктированных раковых пептидов, образовавшихся в результате естественного процессинга | |
EA201692394A1 (ru) | Антитела и антигенсвязывающие фрагменты, которые специфично связываются с белком тау, ассоциированным с микротрубочками | |
BR112018011073A2 (pt) | anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes e métodos de utilização | |
UY36304A (es) | Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes | |
BR112019018307A2 (pt) | Plataforma para identificação de peptídeos imunogênicos baseada em população | |
BR112017006736A2 (pt) | anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização | |
BR112016027805A2 (pt) | receptores de células t do anti-papilomavírus humano 16 e7 | |
BR112017006598A2 (pt) | anticorpo de repetições antidipeptídeo derivado de ser humano (dprs) | |
BR112014026755B8 (pt) | anticorpos contra claudin 18.2 úteis no diagnóstico de câncer | |
EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
BR112019012796A2 (pt) | proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas | |
BR112017009790A2 (pt) | anticorpos direcionados ao anti-ang2 e métodos de uso | |
BR112015008036A2 (pt) | população de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica e kit | |
MX2017008096A (es) | Pestivirus. | |
MX2016013584A (es) | Parvovirus porcino. | |
BR112018008840A8 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
BR112017002622A2 (pt) | métodos e sistemas para quantificação seletiva e detecção de alergênicos | |
BR112016015537A2 (pt) | métodos e kits para detectar a presença de sequência polinucleotídea da e. histolytica em amostra | |
BR112018073660A2 (pt) | anticorpos anti-fator ix pádua |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: ABAXIS LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: ZOETIS SERVICES LLC (US) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/01/2015, OBSERVADAS AS CONDICOES LEGAIS |